Stockscreener 앱 받기
21.80
0.05%
0.01
Arcus Biosciences Inc 주식(RCUS)의 최신 뉴스
Arcus Biosciences appoints new Chief Medical Officer - MSN
Arcus Biosciences (NYSE:RCUS) Trading Down 5.8%Time to Sell? - MarketBeat
Is Arcus Biosciences (RCUS) Using Casdatifan to Quietly Redefine Its Core Oncology Strategy? - Sahm
Goldman Sachs Upgrades Arcus Biosciences (RCUS) to 'Buy', Raises Price Target | RCUS Stock News - GuruFocus
Goldman Sachs Upgrades Arcus Biosciences (RCUS) - Nasdaq
Understanding the Setup: (RCUS) and Scalable Risk - Stock Traders Daily
Arcus Biosciences stock jumps on Goldman upgrade as traders eye JPM Healthcare stage - TechStock²
Arcus Biosciences (NYSE:RCUS) Shares Gap UpHere's What Happened - MarketBeat
Goldman Sachs resumes Arcus Biosciences stock coverage with Buy rating By Investing.com - Investing.com Nigeria
Goldman Sachs resumes Arcus Biosciences stock coverage with Buy rating - Investing.com India
Risk Check: What is Arcus Biosciences Incs valuation compared to sectorJuly 2025 Big Picture & High Accuracy Investment Signals - baoquankhu1.vn
Arcus downgraded at Morgan Stanley on balanced risk-reward setup - MSN
Arcus Biosciences (RCUS) Valuation Check After Recent Share Price Pullback And 1 Year Gain - Yahoo Finance
Los Angeles Daily NewsArcus Biosciences, Inc. Common Stock (NYSE:RCUS) Stock Quote - FinancialContent
Can Arcus Biosciences Inc. stock double in next 5 yearsMarket Performance Recap & AI Enhanced Trade Execution Alerts - Улправда
Arcus Biosciences (RCUS) CEO Terry Rosen donates 35,000 shares in Form 4 - Stock Titan
Will Arcus Biosciences Inc. stock recover faster than marketMarket Movers & Weekly High Return Forecasts - ulpravda.ru
Arcus Biosciences, Inc. (RCUS) Investor Outlook: Exploring A 48.95% Upside Potential - DirectorsTalk Interviews
Arcus Biosciences, Inc. (NYSE:RCUS) Receives Consensus Rating of "Moderate Buy" from Brokerages - MarketBeat
Will Arcus Biosciences Inc. stock continue upward momentumWatch List & AI Optimized Trade Strategies - ulpravda.ru
Is Arcus Biosciences Inc. stock a buy for dividend growthWeekly Market Outlook & Smart Allocation Stock Tips - Улправда
Growth Review: Is Arcus Biosciences Inc. stock a buy for dividend growth2025 Trading Volume Trends & Fast Moving Stock Trade Plans - Улправда
Arcus Biosciences (RCUS) Downgraded by Morgan Stanley Amid Recen - GuruFocus
Is Arcus Biosciences Inc. stock attractive after correctionMarket Sentiment Report & Precise Trade Entry Recommendations - ulpravda.ru
Arcus Biosciences (NYSE:RCUS) stock slides on Morgan Stanley downgrade as casdatifan 2026 timeline sharpens - TechStock²
BlackRock (RCUS) Schedule 13G/A shows 12.7M Arcus Biosciences shares owned - Stock Titan
Will Arcus Biosciences Inc. stock maintain growth storyJuly 2025 Earnings & Accurate Buy Signal Alerts - Улправда
Arcus stock downgraded at Morgan Stanley (RCUS:NYSE) - Seeking Alpha
Arcus Biosciences (NYSE:RCUS) Shares Gap Down on Insider Selling - MarketBeat
Morgan Stanley Downgrades Arcus Biosciences (RCUS), Adjusts Pric - GuruFocus
Morgan Stanley downgrades Arcus Biosciences stock on balanced risk/reward - Investing.com Canada
Insider Selling: Arcus Biosciences (NYSE:RCUS) President Sells 31,823 Shares of Stock - MarketBeat
Arcus Biosciences (RCUS) Sets Ambitious 2026 Agenda for Casdatif - GuruFocus
Biotech outlines 2026 plans for kidney cancer and atopic dermatitis - Stock Titan
Arcus Biosciences President Sells $2 Million as Stock Delivers 48% Annual Return - Yahoo Finance
RCUS (NYSE: RCUS) trust files Rule 144 to sell 31,823 Class A shares - Stock Titan
RCUS SEC FilingsArcus Bioscience 10-K, 10-Q, 8-K Forms - Stock Titan
Arcus Biosciences (RCUS) Shares Fall by Over 9% - GuruFocus
Arcus Biosciences (NYSE:RCUS) Trading Down 7.8% Following Insider Selling - MarketBeat
Portfolio Shifts: Is Arcus Biosciences Inc stock a buy for dividend growthLong Setup & AI Powered Buy and Sell Recommendations - Bộ Nội Vụ
Insider Sell: Goeltz II Robert C. Sells Shares of Arcus Bioscien - GuruFocus
Arcus Biosciences appoints new board member - MSN
Insider Selling: Arcus Biosciences (NYSE:RCUS) CFO Sells 6,552 Shares of Stock - MarketBeat
Arcus Biosciences (RCUS) CFO reports 6,552-share sale under 10b5-1 plan - Stock Titan
Arcus Biosciences (RCUS) CEO moves 2,400 shares to family trusts - Stock Titan
The Technical Signals Behind (RCUS) That Institutions Follow - Stock Traders Daily
Arcus Biosciences (NYSE:RCUS) Trading Up 2.8%Should You Buy? - MarketBeat
Certain Common Stock of Arcus Biosciences, Inc. are subject to a Lock-Up Agreement Ending on 30-DEC-2025. - marketscreener.com
Certain Stock Optios of Arcus Biosciences, Inc. are subject to a Lock-Up Agreement Ending on 30-DEC-2025. - marketscreener.com
Certain Restricted Stock Units of Arcus Biosciences, Inc. are subject to a Lock-Up Agreement Ending on 30-DEC-2025. - MarketScreener
Arcus Biosciences Earnings Notes - Trefis
Is Arcus Biosciences Inc a good long term investmentDebt-to-Equity Ratio Analysis & AI-Based Predictions Available Free - earlytimes.in
Understanding Momentum Shifts in (RCUS) - news.stocktradersdaily.com
Can Arcus Biosciences Inc. stock deliver consistent earnings growthQuarterly Investment Review & Comprehensive Market Scan Reports - Улправда
Have Insiders Sold Arcus Biosciences Shares Recently? - simplywall.st
Squarepoint Ops LLC Boosts Stake in Arcus Biosciences, Inc. $RCUS - MarketBeat
Can Arcus Biosciences Inc. stock deliver sustainable ROEMarket Sentiment Report & Technical Confirmation Trade Alerts - Улправда
How higher bond yields impact Arcus Biosciences Inc. stockJuly 2025 Breakouts & Safe Entry Trade Signal Reports - ulpravda.ru
4.73%
0.92%
자본화:
|
볼륨(24시간):